May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Inhibition of Proliferation of Cultured Human Tenon's Capsule Fibroblasts by the PDGF-receptor Specific Tyrphostin AG 1295 after Stimulation with PDGF-BB
Author Affiliations & Notes
  • J. Von Eicken
    University Eye Hospital, Tübingen, Germany
  • U. Birk
    University Eye Hospital, Tübingen, Germany
  • S. Grisanti
    University Eye Hospital, Tübingen, Germany
  • O. Denk
    University Eye Hospital, Tübingen, Germany
  • Footnotes
    Commercial Relationships  J. Von Eicken, None; U. Birk, None; S. Grisanti, None; O. Denk, None.
  • Footnotes
    Support  Ernst und Berta Grimmke Stiftung
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 1189. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      J. Von Eicken, U. Birk, S. Grisanti, O. Denk; Inhibition of Proliferation of Cultured Human Tenon's Capsule Fibroblasts by the PDGF-receptor Specific Tyrphostin AG 1295 after Stimulation with PDGF-BB . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1189.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: We have previously shown that PDGF-isoforms are potent stimulators of proliferation of cultured human tenon's capsule fibroblasts. In the present study we investigated the antiproliferative effects of the tyrphostin AG-1295, a PDGF-receptor-ß-specific tyrosine kinase inhibitor, on cultured human tenons capsule fibroblasts (HTF) after stimulation with PDGF-BB. Methods: HTF were grown from small tissue biopsies which were obtained during pars plana vitrectomies. Proliferation of cultured HTF upon stimulation with 50 ng/ml PDGF-BB was inhibited using increasing concentrations of AG 1295 diluted in DMSO (0.1, 1, 10, and 100 µmol/l). Cells treated with PDGF-BB and DMSO only (0.001%, 0.01%, 0.1% and 1%) served as control. The cells were harvested with trypsin/EDTA on days 1, 3, 5, 8, 10 and cell number was determined using a computer-based cell counter system (Schärfe Systems, Reutlingen, Germany). Results: Compared with the DMSO-treated controls, we observed a significant reduction of proliferation when cells were treated with 100 µmol/l AG-1295. Inhibition of PDGF-BB induced proliferation of HTF was maximal after 5 days in culture (11.2-fold). Less but still significant inhibition was found after 3 days (3.9-fold), 8 days (4.8-fold) and 10-days (3.8-fold). More over lower levels of AG-1295 induced a dose dependent inhibition. Conclusion: The results of the present study show for the first time, that AG-1295 is a potent pharmacological agent for the inhibition of PDGF-stimulated HTF cell proliferation. It may therefore serve as a therapeutical tool to inhibit the repair reaction after glaucoma filtering surgery.

Keywords: wound healing • pharmacology • cytokines/chemokines 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×